类癌心脏病手术治疗结局的系统综述与荟萃分析
该系统综述与荟萃分析纳入9项研究共416例类癌心脏病手术患者,汇总围术期细节与长期结局。
要点
- 98%患者存在肝转移,75%原发神经内分泌肿瘤位于小肠或结肠。
- 三尖瓣置换率99%,生物瓣使用率80%,住院时间平均16天。
核心结论
- 对于>18岁患者,类癌心脏病手术治疗具有合理的安全性,但总体生存似乎持续受原发疾病影响。
研究设计与样本
- 系统综述与荟萃分析,检索Ovid、Scopus、CINAHL和Cochrane对照试验注册库,纳入9篇文章共416例患者,提取研究水平数据合并分析。
主要发现
- 患者平均年龄63岁(95%CI 57-70),男性占53%(95%CI 46-61)。
- 75%(95%CI 54-96)的神经内分泌肿瘤起源于小肠或结肠,98%(95%CI 93-100)存在肝转移。
- 48%(95%CI 14-81)存在右心衰竭;三尖瓣中度或重度反流占97%(95%CI 95-99),肺动脉瓣占72%(95%CI 58-83)。
- 99%(95%CI 98-100)的三尖瓣和59%(95%CI 38-79)的肺动脉瓣被置换,三尖瓣位置生物瓣使用率为80%(95%CI 68-93)。
临床怎么用
- 对于>18岁类癌心脏病患者,可考虑手术治疗,但需充分评估原发神经内分泌肿瘤的持续影响及肝转移情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carcinoid heart disease (CaHD) develops from vasoactive substances released by neuroendocrine tumors, which can cause significant patient morbidity and mortality without surgical intervention. We performed a systematic review and meta-analysis to elucidate granular perioperative details and long-term outcomes in these patients. METHODS: Electronic search of Ovid, Scopus, Cumulative Index of Nursing and Allied Health Literature, and Cochrane Controlled Trials Register was performed to examine surgical treatment of carcinoid disease. Nine articles comprising 416 patients were selected. Study-level data were extracted and pooled for meta-analysis. RESULTS: Mean patient age was 63 years (95% confidence interval, 57-70) with 53% (95% confidence interval, 46-61) of patients being male. In addition, 75% (95% confidence interval, 54-96) of neuroendocrine tumors originated from the small bowel or colon and 98% (95% confidence interval, 93-100) had liver metastases. Right heart failure was present in 48% (95% confidence interval, 14-81). Moderate or severe regurgitation was present in 97% (95% confidence interval, 95-99) of tricuspid and 72% (95% confidence interval, 58-83) of pulmonary valves. In addition, 99% (95% confidence interval, 98-100) of tricuspid and 59% (95% confidence interval, 38-79) of pulmonary valves were replaced. Bioprosthetic valves were used in 80% (95% confidence interval, 68-93) of tricuspid positions. Mean hospital duration of stay was 16 days (95% confidence interval, 7-25). Thirty-day mortality was 9% (95% confidence interval, 6-12). Mean follow-up was 25 months (95% confidence interval, 11-39). Median survival was 3 years (95% confidence interval, 2.5-3.5). CONCLUSION: For patients >18 years of age, surgical treatment of carcinoid heart disease can be performed with a reasonable safety profile. However, overall survival appears to have ongoing effects of the primary disease.
引用
- O'Malley TJ, Jimenez DC, Saxena A, et al. Outcomes of surgical treatment for carcinoid heart disease: A systematic review and meta-analysis. Surgery. 2021. PMID: 33812754. doi:10.1016/j.surg.2021.02.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。